Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
48.10
+3.21 (7.15%)
Nov 22, 2024, 4:00 PM EST - Market closed
Tectonic Therapeutic Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 14 | 7.68 | 7.18 | 4.63 |
| Research & Development | 39.4 | 36.97 | 25.65 | 10.98 |
| Operating Expenses | 53.4 | 44.65 | 32.83 | 15.61 |
| Operating Income | -53.4 | -44.65 | -32.83 | -15.61 |
| Interest Expense | -0.12 | -0.15 | -0.14 | -0.45 |
| Interest & Investment Income | 2.66 | 0.58 | 0.15 | - |
| Other Non Operating Income (Expenses) | -2.62 | 1.4 | 0.65 | 8.1 |
| EBT Excluding Unusual Items | -53.48 | -42.82 | -32.18 | -7.96 |
| Other Unusual Items | - | - | - | -0.97 |
| Pretax Income | -53.48 | -42.82 | -32.18 | -8.93 |
| Net Income | -53.48 | -42.82 | -32.18 | -8.93 |
| Net Income to Common | -53.48 | -42.82 | -32.18 | -8.93 |
| Shares Outstanding (Basic) | 15 | 3 | 3 | - |
| Shares Outstanding (Diluted) | 15 | 3 | 3 | - |
| Shares Change (YoY) | 482.85% | 4.29% | - | - |
| EPS (Basic) | -3.63 | -16.26 | -12.74 | - |
| EPS (Diluted) | -3.63 | -16.26 | -12.74 | - |
| Free Cash Flow | - | -40.96 | -29.73 | -14.58 |
| Free Cash Flow Per Share | - | -15.55 | -11.77 | - |
| EBITDA | -52.02 | -43.17 | -31.82 | -15.25 |
| D&A For EBITDA | 1.38 | 1.48 | 1.01 | 0.36 |
| EBIT | -53.4 | -44.65 | -32.83 | -15.61 |
Source: S&P Capital IQ. Standard template.
Financial Sources.